BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs ...
Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing ...
Walt Disney Co. is investing $1 billion in OpenAI under a new commercial partnership with the ChatGPT and Sora developer. The three-year licensing agreement will allow users of Sora, OpenAI's ...
Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to ...
Apple has moved on to the second round of developer betas for the current testing generation, with fresh builds of iOS 26.2, iPadOS 26.2, watchOS 26.2, tvOS 26.2, visionOS 26.2, and macOS Tahoe 26.2 ...
CALGARY, Alberta, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) today announced that it has entered into a multi-year software licensing agreement ...
Apple’s latest iPhone software is iOS 26. Released in mid-September, it was followed by a small bug-fix update in the form of iOS 26.0.1. Now, there’s the first major update, with new features as well ...
An update from Phoenix New Media ( (FENG)) is now available. On November 5, 2025, Phoenix New Media Limited announced a new program license agreement with Phoenix Satellite Television Holdings Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback